New Study Tracks Pharmaceutical Fraud and Abuse in the United States, 1996-2010

In a recent article in the Archives of Internal Medicine, Zaina Qureshi and colleagues report that between 1996 and 2005, $3.6 billion wasrecovered for 13 pharmaceutical fraud cases initiated by “whistleblowers” and that since 1996, a total of $12 billion has been recovered from 31 pharmaceutical prosecutions for violations of the False Claims Act. The authors conclude that “industrywide changes in the way pharmaceutical corporations conduct marketing activities are needed.”